Journal of Pharmacology and Clinical Trials


Aim and scope: Our aim is to encourage scientists to publish their experimental results and theoretical assumptions in as much detail as possible.

NorCal open access seeks to promote clinical and scientific research using online tools that showcase researchers, clinicians, and physicians around the globe. NorCal Open Access is always looking forward to publish manuscripts in the field of pharmacology and clinical research, which provide novel insights and discoveries emerging from sublime research laboratories to enhance our daily living. All the manuscripts undergo rigorous double-blind peer-review process carefully assessed by clinical experts.

Journal of pharmacology and clinical trials (JPCT) is an open access journal which provides an advanced forum for the science and technology of pharmacology and clinical trials manuscripts like research, review, mini reviews, case reports and studies, short communications, letters, editorials, etc. from all the aspects of Pharmaceutical Sciences. Covered topics include pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. Our Journal publishes manuscripts including but not limited to following topics:

Affinity, Agonist and Efficacy Hepato-Biliary Diseases
Pharmacodynamics and Pharmacokinetics Drug Regulation
Specificity and Selectivity Vascular Pharmacology
Benzodiazepines Metabolic Pharmacology
Pharmacotherapy Renal Pharmacology
Plasma Protein Binding Respiratory System Pharmacology
Adverse Drug Reactions (ADR) Urogenital Tract Pharmacology
Metabolism Antidiabetic Drugs
Idiosyncratic Effect Antimicrobial Drug Development
Hypersensitivity Translational Drug Development
Biotransformation Drug Action and Drug Effects
Biotechnology Drug Development Research
Bioavailability Drug Interactions
Drug Neuropsychopharmacology
Anxiolytic Drug Nomenclature


Contact the journal:
Please do not hesitate to get in touch, get your queries clarified via the email address below: